Comparison of Lower Limb Endovascular Interventions With and Without the EndoNaut Workstation

Therenva200 enrolled

Overview

To demonstrate that the use of EndoNaut for endovascular procedures on the femoropopliteal axis has a clinical impact for the patient (decrease in irradiation and the volume of contrast product) as well as for nursing staff (reduction in irradiation) compared to procedures performed without EndoNaut.

Peripheral artery disease (PAD) is characterized by a narrowing of the size of arteries, which resulting in a loss of hemodynamic load. Endovascular (or percutaneous) procedures performed at the infrainguinal level (axefemoro-popliteal) are very common in affected patients. Therenva offers a complete and consistent lightweight navigation solution (EndoNaut®) based on artificial intelligence (AI) algorithms, and providing technology accessible to all operating rooms for PAD procedures. The aim of this study is to demonstrate that the use of EndoNaut for endovascular procedures on the femoropopliteal axis has a clinical impact for the patient (decrease in irradiation and the volume of contrast product) as well as for nursing staff (reduction in irradiation) compared to the procedures performed by EndoNaut.

Study Type

OBSERVATIONAL

Enrollment

200

Conditions

Peripheral Arterial Disease

Interventions

Endovascular procedurePROCEDURE

Creation of a bone and arterial panorama using EndoNaut® software. The routine care procedure begins with staged injections of contrast medium to provide a map of the lesions. The lesions are then treated by angioplasty with or without stenting.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with peripheral arterial disease of the lower limbs, all clinical stages, lesions of the femoro-popliteal stage and candidates for endovascular treatment of these lesions. * Major patients * Patients not opposed to their participation in the study Exclusion Criteria: \- Patients requiring conventional surgical revascularization.

Locations (1)

CH Libourne

Libourne, France

Outcomes

Primary Outcomes

Volume of contrast product used during the routine care procedure (ml)

Volume are reported in mL

Time frame: 1 day At enrollment

Irradiation parameters: evaluation of the Fluoroscopy duration (min)

Parameter given by the X-ray imaging device

Time frame: 1 day At enrollment

Irradiation parameters: dose-area quantification (mGy/m2)

Parameter given by the X-ray imaging device

Time frame: 1 day At enrollment

Irradiation parameters: measurement of air Kerma (mGy)

Parameter given by the X-ray imaging device

Time frame: 1 day At enrollment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.